Showing 1–6 of 12 results

De nos jours, il est très facile de trouver des casinos en ligne réputés où le choix des jeux et des bonus spéciaux est presque incommensurable. Mais à quoi devez-vous faire attention? Y a-t-il des choses importantes à savoir pour les débutants et les professionnels afin que vous puissiez également jouer détendu et en toute conscience? Dans notre expérience de casino en ligne, nous nous concentrons exclusivement sur les casinos en ligne de bonne réputation. Cela signifie que nos clients peuvent se sentir en sécurité à tout moment lorsqu’ils déposent de l’argent réel et tentent leur chance sur des milliers de machines à sous, de roulette, de blackjack et de tables de baccara véritables machines à sous en ligne Avant de poser trop de questions ici, la chose la plus importante d’abord: sur notre gide, vous trouverez la meilleure sélection de casinos en ligne réputés. Il n’est pas seulement important pour nous d’offrir des casinos avec de nombreux jeux
0.00 Excl. VAT

CONTENTS   211 Ongoing Trials in More than 10 Therapeutic Areas   106 Sponsors from 13 Countries Have Initiated These 211 Ongoing Trials   68 % of On Going Trials with At Least One Location in the USA   72 % of On Going Trials with At Least One Location in Europe   AAV-Based Vectors [...]

390.00 Excl. VAT

BioNTech, CureVac, Moderna Therapeutics, Translate Bio…. These four biotech are the main state-of-the-art companies at the forefront in mRNA science. All of them are now developing mRNA-based vaccine candidates against SARS-CoV-2 and have reached the clinical stage. These programs could lead to short-term boosts for these companies’s shares. However, addressing epidemics is still a risky business. So far, it isn’t the [...]

590.00 Excl. VAT

OctopusyX BioConsulting (Olivier REVELANT, @octopusyx2), a member of Eurobiomed, and BioPharmAnalyses (Anne-Lise BERTHIER, @anneliseberthie) are proud to announce the launch of their new report entitled "AAV-based Gene Therapy Products: Ongoing Clinical Trials". This >200 pages report provides a unique exhaustive overview of 116 ongoing trials for the treatment of 40 diseases (as of June 2020). More thant 80 AAV based products described. Wishing to identify hot research topics  in this highly competitive field ?   Looking for an update on the clinical portfolio ?   Needing insights to assist you in your decision-making  or to identify the most advanced companies in the field ?   Searching for new candidates to in-license ?   ● 205 pages detailing 116 clinical trials for the treatment of 40 diseases   ● 49 companies and academic institutions developing more than 80 AAVbased gene therapy products in a wide range of therapeutic areas (Cardiovascular Diseases, Hematological Diseases, Hepatic Diseases, Infectious Diseases, inherited Metabolic Diseases, Lysosomal Diseases, Neurological Diseases, Neuromuscular Diseases and Ophthalmological Diseases) Want to have a look at this report ? Click to download sample pages (http://biopharmanalyses.fr/wp-content/uploads/2020/06/sample-pages.pdf) Order Form (http://biopharmanalyses.fr/wp-content/uploads/2020/06/order-form.pdf)

990.00 Excl. VAT

RNA science is now translated into new therapies… Six RNA-based products are now approved More than one hundred candidates have reached the clinical stage…  “BRIEFING ON RNA TRIALS” provides you an accurate overview to explore the latest trials in this dynamic and rapidly evolving field FOUR REASONS TO BUY: Wishing to identify hot research topics in [...]

1,090.00 Excl. VAT

BioPharmAnalyses and Octopusyx BioConsulting are happy to announce the release of the second issue of their “BRIEFING ON CART-T CELLS TRIALS”   At least 5 reasons to buy “BRIEFING ON CART-T CELLS TRIALS” More than 140 new clinical trials registered between 01/01/2018 and 12/01/2019 For each clinical trial mentioned, a novel format enriched by relevant contextualisation [...]